Kyle M. Devins

907 total citations
41 papers, 195 citations indexed

About

Kyle M. Devins is a scholar working on Pulmonary and Respiratory Medicine, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Kyle M. Devins has authored 41 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Reproductive Medicine and 11 papers in Obstetrics and Gynecology. Recurrent topics in Kyle M. Devins's work include Ovarian cancer diagnosis and treatment (13 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Sarcoma Diagnosis and Treatment (6 papers). Kyle M. Devins is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Sarcoma Diagnosis and Treatment (6 papers). Kyle M. Devins collaborates with scholars based in United States, Italy and Canada. Kyle M. Devins's co-authors include Robert H. Young, Esther Oliva, Jaclyn C. Watkins, John P. Wilson, Darryl Pappin, John Wojcik, Dylan M. Marchione, Benjamin A. García, G. Petur Nielsen and Zubair Baloch and has published in prestigious journals such as British Journal of Cancer, The American Journal of Surgical Pathology and Human Pathology.

In The Last Decade

Kyle M. Devins

32 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle M. Devins United States 9 66 49 43 41 38 41 195
Jennifer X. Ji Canada 7 107 1.6× 36 0.7× 56 1.3× 33 0.8× 32 0.8× 9 219
Jitka Hausnerová Czechia 10 142 2.2× 34 0.7× 84 2.0× 70 1.7× 63 1.7× 37 297
Nicole E. James United States 12 75 1.1× 53 1.1× 87 2.0× 91 2.2× 11 0.3× 32 298
Nicolas Pouget France 8 23 0.3× 20 0.4× 72 1.7× 47 1.1× 59 1.6× 15 190
Hélène Vanacker France 9 54 0.8× 99 2.0× 37 0.9× 87 2.1× 32 0.8× 33 226
Nikola Hájková Czechia 9 79 1.2× 37 0.8× 61 1.4× 69 1.7× 44 1.2× 25 194
Monica Ragnoli Italy 7 60 0.9× 26 0.5× 206 4.8× 41 1.0× 165 4.3× 9 296
Jana Drozenová Czechia 8 49 0.7× 34 0.7× 45 1.0× 66 1.6× 26 0.7× 29 202
Ari Reiss Israel 6 65 1.0× 72 1.5× 33 0.8× 37 0.9× 35 0.9× 20 169
S. Suchetha India 9 48 0.7× 25 0.5× 82 1.9× 55 1.3× 71 1.9× 35 235

Countries citing papers authored by Kyle M. Devins

Since Specialization
Citations

This map shows the geographic impact of Kyle M. Devins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle M. Devins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle M. Devins more than expected).

Fields of papers citing papers by Kyle M. Devins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle M. Devins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle M. Devins. The network helps show where Kyle M. Devins may publish in the future.

Co-authorship network of co-authors of Kyle M. Devins

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle M. Devins. A scholar is included among the top collaborators of Kyle M. Devins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle M. Devins. Kyle M. Devins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, David, Kenneth Chen, Jennifer N. Stall, et al.. (2025). Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor. JCO Precision Oncology. 9(9). e2400902–e2400902. 1 indexed citations
2.
3.
Lin, Lawrence Hsu, Kyle M. Devins, Gulisa Turashvili, et al.. (2025). 995 Clinicopathologic Features and Isochromosome 12p Status of Uterine Teratomas: A Report of 6 Cases. Laboratory Investigation. 105(3). 103229–103229. 1 indexed citations
4.
Devins, Kyle M., Adam S. Fisch, Robert H. Young, Dora Dias‐Santagata, & Esther Oliva. (2025). GLI1-Altered Tumors of the Ovary: A Report of 4 Cases of an Underrecognized Neoplasm That May Mimic Sex Cord–Stromal Tumors. Modern Pathology. 38(12). 100848–100848.
5.
Turashvili, Gulisa, Sabrina Croce, Olesya Solheim, et al.. (2025). A Distinctive DICER1-Related Wilms-Like Uterine Tumor: A Report of Eight Cases. Modern Pathology. 38(12). 100895–100895.
6.
Young, Robert H., et al.. (2025). Adult Granulosa Cell Tumors of the Ovary With Tubular Differentiation. The American Journal of Surgical Pathology. 49(8). 770–780. 1 indexed citations
7.
Devins, Kyle M., et al.. (2025). Somatic Malignancies Arising in Ovarian Mature Cystic Teratomas. The American Journal of Surgical Pathology. 49(6). 527–538.
9.
Devins, Kyle M., Robert H. Young, & Esther Oliva. (2024). Sex Cord-Stromal Tumors of the Ovary: An Update and Review. Part II — Pure Sex Cord and Sex Cord-Stromal Tumors. Advances in Anatomic Pathology. 31(4). 231–250. 1 indexed citations
10.
Matoba, Yusuke, Venkatesh Pooladanda, Maryam Azimi, et al.. (2024). Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma. British Journal of Cancer. 130(9). 1463–1476. 6 indexed citations
11.
Banet, Natalie, Carlos Parra‐Herran, Joseph T. Rabban, et al.. (2024). Gynecologic Pathology Journal Club: A 2-year, Worldwide Virtual Learning Experience With a Focus on Mentorship and Inclusion. International Journal of Gynecological Pathology. 43(6). 652–660. 3 indexed citations
12.
Devins, Kyle M., Wesley Samore, G. Petur Nielsen, Vikram Deshpande, & Esther Oliva. (2023). Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors. Modern Pathology. 36(6). 100143–100143. 13 indexed citations
13.
Ferrari, Adam J., Akshaya V. Annapragada, Yasuto Kinose, et al.. (2023). H2Bub1 loss is an early contributor to clear cell ovarian cancer progression. JCI Insight. 8(12). 4 indexed citations
14.
Devins, Kyle M., Kaitlyn E. James, Amy Bregar, et al.. (2023). Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary. International Journal of Gynecological Cancer. 33(9). 1434–1439. 2 indexed citations
15.
Devins, Kyle M., et al.. (2022). Cystic Walthard Nests of the Peritoneal Diaphragm: A Report of 3 Cases of a Common Process at an Unusual Site and Occurring in Patients With Endometriosis. International Journal of Gynecological Pathology. 42(2). 196–200.
16.
Cornejo, Kristine M., Esther Oliva, Peter M. Sadow, et al.. (2022). Clinicopathologic features and proposed grossing protocol of orchiectomy specimens performed for gender affirmation surgery. Human Pathology. 127. 21–27. 7 indexed citations
17.
Devins, Kyle M., Lawrence Zukerberg, Jaclyn C. Watkins, Yin P. Hung, & Esther Oliva. (2022). BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma. International Journal of Gynecological Pathology. 42(2). 159–166. 8 indexed citations
18.
Doberstein, Kai, Hunter D. Reavis, Jagmohan Hooda, et al.. (2022). L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary. Communications Biology. 5(1). 1362–1362. 11 indexed citations
19.
20.
Devins, Kyle M., Stephen J. Schuster, Gabriel C. Caponetti, & Agata M. Bogusz. (2018). Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation. Diagnostic Pathology. 13(1). 92–92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026